A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans
Author:
Funder
Abbott Fund
Pfizer
Assistance publique-Hôpitaux de Paris
Bayer
Novartis Pharma
AstraZeneca France
Publisher
Elsevier BV
Subject
Cell Biology,Dermatology,Molecular Biology,Biochemistry
Reference39 articles.
1. Sample size tables for exact single-stage phase II designs;A’Hern;Stat Med,2001
2. Gene expression profiling of human sarcomas: insights into sarcoma biology;Baird;Cancer Res,2005
3. Controlling the false discovery rate: a practical and powerful approach to multiple testing;Benjamini;J R Stat Soc Series B (Methodol),1995
4. Validation of VEGFR1 rs9582036 as predictive biomarker in metastatic clear-cell renal cell carcinoma patients treated with sunitinib;Beuselinck;BJU Int,2016
5. Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade;Chao;Ann Surg Oncol,2001
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multi-omic profiling and real time ex vivo modelling of imatinib-resistant dermatofibrosarcoma protuberans with fibrosarcomatous transformation;Human Cell;2023-08-23
2. Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to COL1A1‐PDGFB fusion gene;Cancer Science;2023-08-17
3. Tyrosine kinase inhibitors versus radiation therapy in unresectable dermatofibrosarcoma protuberans (DFSP): A narrative systematic review;The American Journal of Surgery;2023-02
4. Dermatofibrosarcoma Protuberans: What Is This?;Surgical Clinics of North America;2022-08
5. Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3